Thursday, September 29, 2016

Synthetic Conjugated Estrogens A


Synthetic Conjugated Estrogens A is a brand name of conjugated estrogens topical, approved by the FDA in the following formulation(s):


SYNTHETIC CONJUGATED ESTROGENS A (estrogens, conjugated synthetic a - cream; vaginal)



  • Manufacturer: TEVA WOMENS

    Approval date: November 28, 2008

    Strength(s): 0.625MG/GM [RLD]

Has a generic version of Synthetic Conjugated Estrogens A been approved?


No. There is currently no therapeutically equivalent version of Synthetic Conjugated Estrogens A available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Synthetic Conjugated Estrogens A. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Synthetic Conjugated Estrogens A.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • November 28, 2011 - NEW PRODUCT

See also...

  • SCE-A Consumer Information (Drugs.com)
  • SCE-A Cream Consumer Information (Wolters Kluwer)
  • Synthetic Conjugated Estrogens, A Cream Consumer Information (Wolters Kluwer)
  • Synthetic Conjugated Estrogens, A vaginal Consumer Information (Cerner Multum)
  • Conjugated Estrogens Cream Consumer Information (Wolters Kluwer)
  • Premarin Cream Consumer Information (Wolters Kluwer)
  • Premarin vaginal Consumer Information (Cerner Multum)
  • Conjugated estrogens vaginal Consumer Information (Cerner Multum)

No comments:

Post a Comment